Physician profile
Jessica Elizabeth Andrews
NPI 1437670569
$11,446.55
in general payments reported to CMS, 2019-2025
27 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,777 · 2020: $204 · 2021: $4,015 · 2022: $3,572 · 2023: $1,562 · 2024: $41.62 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $977 · Travel and Lodging: $901.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.44 |
| Travel and Lodging | $901.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,948.18 | 2021-2023 | Distal Extremities Implants Soft Tissue Ib Ligament Augmentation |
| Medline Industries Lp | $1,191.25 | 2023 | |
| Mid-Atlantic Surgical Systems, LLC | $1,185.84 | 2019 | |
| Novastep INC. | $993.69 | 2021-2022 | |
| Horizon Therapeutics Plc | $361.51 | 2019-2022 | |
| Smith+Nephew, INC. | $319.05 | 2019-2020 | |
| Coastal Medical Technologies LLC | $169.33 | 2023-2025 | |
| Stryker Corporation | $165.45 | 2020-2021 | |
| Organogenesis INC. | $144.08 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $135.56 | 2023-2025 | Nuzyra |
| Ortho Solutions INC | $131.37 | 2021 | |
| Trilliant Surgical LLC. | $130.89 | 2021 | |
| Orthofix Medical, INC. | $118.12 | 2021 | |
| Djo, LLC | $94.43 | 2022 | |
| Medical Device Business Services, INC. | $79.25 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $56.44 | 2022-2024 | |
| Metric Medical Devices, INC. | $35.06 | 2022 | |
| Reprise Biomedical, INC. | $27.01 | 2024 | Miro3d |
| Abbott Laboratories | $24.48 | 2021 | |
| Bioventus LLC | $24.02 | 2022 | |
| Aroa Biosurgery Incorporated | $21.41 | 2023 | |
| Arteriocyte Medical Systems, INC. | $18.72 | 2020 | |
| Mvp Orthopedics INC | $16.72 | 2022 | |
| Grt US Holding, INC. | $14.31 | 2022 | |
| Kci USA, INC. | $14.10 | 2021 | |
| Extremity Medical | $13.24 | 2021 | |
| Anika Therapeutics, INC. | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Andrews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.